Breast cancer metastasis to the bone: mechanisms of bone loss
about
In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards BoneClaudin 1 in Breast Cancer: New InsightsRole of bone-anabolic agents in the treatment of breast cancer bone metastasesModulation of osteoclast differentiation and bone resorption by Rho GTPasesCalcium-Sensing Receptor in Breast Physiology and CancerWhat Is Breast in the Bone?Osteoprotegerin in breast cancer: beyond bone remodelingInterpretation of immunohistochemistry data of tumor should consider microenvironmental factors.Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to boneOsteoporosis: a discussion on the past 5 years.Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor statusABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.MicroRNAs in the control of metastatic bone disease.Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways.Pathophysiology of Bone Remodelling and Current Therapeutic Approaches.Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastasesThe prognostic significance of RUNX2 and miR-10a/10b and their inter-relationship in breast cancer.Early growth response 4 is involved in cell proliferation of small cell lung cancer through transcriptional activation of its downstream genesRunx2-Smad signaling impacts the progression of tumor-induced bone diseaseMetastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.Eph receptor and ephrin function in breast, gut, and skin epithelia.The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancerP2X7 Receptor Function in Bone-Related Cancer.Therapeutic actions of curcumin in bone disorders.Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cellsNF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells.Denosumab for treatment of breast cancer bone metastases and beyond.The therapeutic potential of anti-interleukin-20 monoclonal antibody.Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics.Onco-nephrology: current concepts and future perspectives.Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer.The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts.Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management.ODAM inhibits RhoA-dependent invasion in breast cancer.Curcumin analog UBS109 prevents bone marrow osteoblastogenesis and osteoclastogenesis disordered by coculture with breast cancer MDA-MB-231 bone metastatic cells in vitro.The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases.Development and characterization of murine models of medulloblastoma extraneural growth in bone.The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.ETV5 as a regulator of matrix metalloproteinase 2 in human chondrosarcoma.
P2860
Q26738435-C41E31FF-87F2-437B-A1FA-94DF85D74A82Q26774988-BA58F004-8A0A-4507-8D96-A004975D9D63Q26822732-BEA7F194-2CEB-40BC-B3D8-55E23CC8BC95Q26851553-7300F265-0ECC-42EE-AE8C-6A489A8D5015Q28071486-68B104DA-BDEF-41B5-8478-8C8CB087A2C4Q28078337-FE08C5FF-1B6B-401E-80B4-E5B22C928FA0Q28081803-ABC1C8C5-4341-45E6-8286-264522E4FDE6Q30907606-66C11B20-FC12-4535-ACD7-6DB61FC8C946Q33674212-D02D1068-A3FE-475A-BBA8-FFD3DDCFFE2CQ33700265-8EC8B2FD-706E-449B-9397-B5C47F2A5912Q33702352-E3B4619D-E558-4A9C-95DF-A056E68B00ADQ33739392-53A45084-7273-4C9E-80FE-DE1844A1D82DQ33821326-E25207CE-81B8-475E-B527-A1CE9D1FBE6CQ34147910-40F957D0-5FBD-420C-B903-D5066DC0B1B1Q34209614-F6AB19CD-13F0-48B0-8027-A7790417E8EBQ34222494-B04F550F-B009-48F9-A497-286BCB73EEA4Q34306282-2D57E376-8648-4564-96BB-953BB905C985Q34550071-2CEDD3A8-51CA-497E-817A-CD3EDBCC68EEQ34898865-A1E599B2-31FC-4B83-946E-F5D165A54BFBQ35683618-74F63953-B852-476B-B3F9-97C1F5568762Q36125059-077F69CE-292A-464C-B72C-F066B2277F41Q36190094-FDAACC5B-1EFA-45F8-8CC0-2C3A7AC70E33Q36200053-104983D7-29EE-427C-9837-5A18246F2838Q36639210-00AA15CA-F34A-409A-B58E-948F575BF538Q37269535-CE12B9B6-AA31-41A2-9451-40778C8BC8B5Q37680059-9B7933C9-9493-4A6A-9189-6EF200498D8DQ37986124-2B731B1B-0706-4A57-8FC6-A956F8945CDAQ38210876-BA1033F3-A2BB-458C-A7BB-AEA820493C67Q38263353-927A8079-88C5-4434-AFA6-3A6FB633F5A2Q38382457-1D2BB97F-D7C4-45A0-8D4D-4D62571C3883Q38631833-C27AE9D7-4AA7-47AD-B9BF-C9049F68F3EAQ38733725-DBB5AB2C-D019-427E-B819-4145C491D429Q38805260-A4C4557F-34A1-4DF8-A23F-93A7CE29A4D0Q38836256-916DEDD5-C7A6-4124-89E1-E2DE0B39B6E0Q38938523-D86BA4C1-EB8A-4F98-9EF3-FE11D5857A99Q38940135-9FE7AE03-DF75-4D27-8EA9-1736FF4185BBQ39068608-B8F54C88-4975-4F80-BFC8-66AC2072AEEEQ39180907-91C4834F-BB1A-4181-8BA6-A882EBEFF678Q39187841-16D9DC5E-8C89-471D-8AB6-18C578D672B9Q39280850-65067977-4A23-4A7F-BA9D-83DE3C538950
P2860
Breast cancer metastasis to the bone: mechanisms of bone loss
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Breast cancer metastasis to the bone: mechanisms of bone loss
@ast
Breast cancer metastasis to the bone: mechanisms of bone loss
@en
Breast cancer metastasis to the bone: mechanisms of bone loss
@nl
type
label
Breast cancer metastasis to the bone: mechanisms of bone loss
@ast
Breast cancer metastasis to the bone: mechanisms of bone loss
@en
Breast cancer metastasis to the bone: mechanisms of bone loss
@nl
prefLabel
Breast cancer metastasis to the bone: mechanisms of bone loss
@ast
Breast cancer metastasis to the bone: mechanisms of bone loss
@en
Breast cancer metastasis to the bone: mechanisms of bone loss
@nl
P2860
P921
P356
P1476
Breast cancer metastasis to the bone: mechanisms of bone loss
@en
P2093
Donna M Sosnoski
P2860
P2888
P356
10.1186/BCR2781
P577
2010-12-16T00:00:00Z
P5875
P6179
1040645911